Mechanisms regulating toxicant disposition to the embryo during early pregnancy: An interspecies comparison
Version of Record online: 20 JAN 2005
Copyright © 2005 Wiley-Liss, Inc.
Birth Defects Research Part C: Embryo Today: Reviews
Volume 72, Issue 4, pages 345–360, December 2004
How to Cite
Carney, E. W., Scialli, A. R., Watson, R. E. and DeSesso, J. M. (2004), Mechanisms regulating toxicant disposition to the embryo during early pregnancy: An interspecies comparison. Birth Defects Research Part C: Embryo Today: Reviews, 72: 345–360. doi: 10.1002/bdrc.20027
- Issue online: 20 JAN 2005
- Version of Record online: 20 JAN 2005
- Ethylene Oxide and Derivatives Sector Group of CEFIC (European Chemical Industry Council, Brussels, Belgium)
The dose of toxicant reaching the embryo is a critical determinant of developmental toxicity, and is likely to be a key factor responsible for interspecies variability in response to many test agents. This review compares the mechanisms regulating disposition of toxicants from the maternal circulation to the embryo during organogenesis in humans and the two species used predominantly in regulatory developmental toxicity testing, rats and rabbits. These three species utilize fundamentally different strategies for maternal-embryonic exchange during early pregnancy. Early postimplantation rat embryos rely on the inverted visceral yolk sac placenta, which is in intimate contact with the uterine epithelium and is equipped with an extensive repertoire of transport mechanisms, such as pinocytosis, endocytosis, and specific transporter proteins. Also, the rat yolk sac completely surrounds the embryo, such that the fluid-filled exocoelom survives through most of the period of organogenesis, and can concentrate compounds such as certain weak acids due to pH differences between maternal blood and exocelomic fluid. The early postimplantation rabbit conceptus differs from the rat in that the yolk sac is not closely apposed to the uterus during early organogenesis and does not completely enclose the embryo until relatively later in development (∼GD13). This suggests that the early rabbit yolk sac might be a relatively inefficient transporter, a conclusion supported by limited data with ethylene glycol and one of its predominant metabolites, glycolic acid, given to GD9 rabbits. In humans, maternal-embryo exchange is thought to occur via the chorioallantoic placenta, although it has recently been conjectured that a supplemental route of transfer could occur via absorption into the yolk sac. Knowledge of the mechanisms underlying species-specific embryonic disposition, factored together with other pharmacokinetic characteristics of the test compound and knowledge of critical periods of susceptibility, can be used on a case-by-case basis to make more accurate extrapolations of test animal data to the human. Birth Defects Research (Part C) 72:345–360, 2005. © 2005 Wiley-Liss, Inc.